Issue |
E3S Web of Conf.
Volume 488, 2024
1st International Conference on Advanced Materials & Sustainable Energy Technologies (AMSET2023)
|
|
---|---|---|
Article Number | 03020 | |
Number of page(s) | 13 | |
Section | Green Buildings; Carbon Capture & Recycling of Energy Materials | |
DOI | https://doi.org/10.1051/e3sconf/202448803020 | |
Published online | 06 February 2024 |
Current Progress on Gold Nanoparticle-Mediated Gene Delivery for Human Cancer Treatment
1 Department of Biological Science, School of Medical and Life Sciences, Sunway University, 47500 Petaling Jaya, Malaysia
2 Department of Medical Science, School of Medical and Life Sciences, Sunway University, 47500 Petaling Jaya, Malaysia
* Corresponding author: jason.d3@imail.sunway.edu.my
Cancer treatments have become less effective in recent years, with cancer cells mutating into more non-sensitive against a plethora of chemotherapeutics. While gene therapy can lead to cancer cell sensitization and effective treatment, gene-related drugs are prone to degradation and highly unstable. Nanoparticles can thus be used for the delivery of genes as well as other therapeutic compounds into cancer cells. Gold nanoparticles (AuNPs) have been used in cancer therapy especially for drug delivery due to their ease of synthesis and modification. AuNPs were also considered versatile nanoparticles as their characteristics could be easily customized and modulated for therapy, monitoring, or delivery. Another important characteristic that made AuNPs viable for cancer therapy is surface plasmonic resonance (SPR) which enables hyperthermia-based therapy and imaging. Therefore, utilizing AuNPs novel approaches in multi-modal therapies is achievable, where targeted gene and chemotherapy coupled with other modalities such as hyperthermia-based therapy could be performed. This article reviews several reported cases of AuNPs-based gene therapy as well as notable theranostic therapy that includes SPR characteristic utilization for therapy as well as cancer imaging.
© The Authors, published by EDP Sciences, 2024
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.